StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was $2.16, down 11.1% from the year before. The highest annual figure on record is $2.43 in fiscal 2024.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.16-11.1%
FY2024Dec 31, 2024$2.43+115.0%
FY2023Dec 31, 2023$1.13–
FY2022Dec 31, 2022-$33.52–
FY2021Dec 31, 2021-$40.00–
FY2020Dec 31, 2020-$16.40–

More NewcelX figures

See a number that looks wrong?